PTAB Denies Lupin’s IPR in Win for Pozen – Claimed Tablet That Provided Coordinated Drug Release Not Suggested by Prior Art, Which Had a Preferred Formulation That Provided the Reverse Release

Banner & Witcoff PTAB Highlights. 03/09/2016

Contact Banner Witcoff Share on LinkedIn View this page as a pdf Share on Twitter Email this page Print this page